Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

October 31, 2008

Conditions
Dry Eye Disease
Interventions
DRUG

Hydroxypropyl Guar Galactomannan

One drop per one time in both eyes, once daily (at each visit).One instillation daily in one period and a total of 4 instillations over 4 periods.

DRUG

0.1% sodium hyaluronate ophthalmic solution

One drop per one time in both eyes, once daily (at each visit).One instillation daily in one period and a total of 4 instillations over 4 periods.

Trial Locations (1)

532-0003

Osaka Pharmacology Clinical Research Hospital, Osaka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY